STOCK TITAN

NLS Pharmaceutics Ltd. (NLSP) Stock News, May-Jul 2023

NLSP NASDAQ

Ticker history: NLSP became NCEL (NewcelX Ltd.) on .

NLS Pharmaceutics Ltd. transitioned into NewcelX Ltd. after its completed merger with Kadimastem, creating a clinical-stage biotechnology company focused on cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. Recurring news includes scientific advisory board updates, clinical-development themes in ALS and AstroRx, CNS pipeline additions such as the AEX-6xx series, and diabetes-program references including ITOL-102.

Company updates also cover material agreements, shareholder voting matters, capital-structure disclosures, governance changes, clinical or regulatory communications, and operating and financial results tied to the combined biotechnology business.

-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.09%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.57%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.01%
Tags
conferences
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.01%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.69%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.90%
Tags
management
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.18%
Tags

FAQ

What is the current stock price of NLS Pharmaceutics (NLSP)?

NLS Pharmaceutics (NLSP) last closed at $0.7620. The company now trades as NCEL.